Flinton Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $423K | Hold |
6,813
| – | – | 0.01% | 493 |
|
|
2019
Q2 | $485K | Buy |
6,813
+654
| +11% | +$46.6K | 0.02% | 480 |
|
|
2019
Q1 | $483K | Hold |
6,159
| – | – | 0.02% | 469 |
|
|
2018
Q4 | $521K | Hold |
6,159
| – | – | 0.02% | 408 |
|
|
2018
Q3 | $1.06M | Buy |
6,159
+164
| +3% | +$28.1K | 0.03% | 312 |
|
|
2018
Q2 | $775K | Hold |
5,995
| – | – | 0.03% | 352 |
|
|
2018
Q1 | $618K | Hold |
5,995
| – | – | 0.02% | 369 |
|
|
2017
Q4 | $512K | Buy |
5,995
+1,308
| +28% | +$112K | 0.02% | 422 |
|
|
2017
Q3 | $398K | Buy |
4,687
+926
| +25% | +$78.6K | 0.01% | 440 |
|
|
2017
Q2 | $285K | Buy |
3,761
+1,744
| +86% | +$132K | 0.01% | 495 |
|
|
2017
Q1 | $133K | Buy |
2,017
+382
| +23% | +$25.2K | 0.01% | 575 |
|
|
2016
Q4 | $104K | Buy |
+1,635
| New | +$104K | ﹤0.01% | 588 |
|